MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition

Cancer Research

Volumn 62, Issue 16, 2002, Pages 4781-4790

  Pinkas, Jan ^a   Leder, Philip ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA CATENIN; COLLAGEN GEL; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ZO1;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; BREAST METASTASIS; CARCINOGENESIS; CELL COMMUNICATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE INDUCTION; MALIGNANT TRANSFORMATION; MESENCHYME CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; EPITHELIAL CELLS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEIN-SERINE-THREONINE KINASES;

EID: 0037102190     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Signalling networks that cause cancer
2. Oncogenic kinase signalling
3. Epithelial-mesenchymal transitions in cancer progression
4. Signal transduction through MAP kinase cascades
5. Hyperexpression of mitogen-activated protein kinase in human breast cancer
6. Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer
7. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
8. Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients
9. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
10. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways
11. Development of anticancer drugs targeting the MAP kinase pathway
12. Mammalian MAP kinase signalling cascades
13. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
14. Identification of 2 serine residues of MEK-I that are differentially phosphorylated during activation by raf and MEK kinase
15. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product
16. Regulation of transcription by MAP kinase cascades
17. MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction
18. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals
19. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner
20. Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion
21. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
22. Activated mek1 binds the nuclear myod transcriptional complex to repress transactivation
23. Transformation of mammalian cells by constitutively active MAP kinase kinase
24. Constitutively active mitogen-activated protein kinase kinase MEKI disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells
25. Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry
26. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes
27. A synthetic inhibitor of the mitogen-activated protein kinase cascade
28. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
29. The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1
30. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells
31. A genome-wide survey of RAS transformation targets
32. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells
33. Basal extracellular signal-regulated kinase activity modulates cell-cell and cell-matrix interactions
34. Epithelial mesenchymal interactions in cancer and development
35. Analysis of the transcriptional program induced by Raf in epithelial cells
36. Blocking oncogenic Ras signaling for cancer therapy
37. Increasing complexity of Ras signal transduction: Involvement of Rho family proteins
38. The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions
39. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells
40. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion
41. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis
42. Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro
43. Properties of mouse mammary epithelial cell lines characterized by in vivo transplantation and in vitro immunocytochemical methods
44. Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function
45. Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents
46. Efficient selection for high-expression transfectants with a novel eukaryotic vector
47. Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells
48. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties
49. Expression of the mouse pre-T cell receptor a gene is controlled by an upstream region containing a transcriptional enhancer
50. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary pads of female C3H mice
51. Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells
52. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism
53. Isolation of EpH4 mammary epithelial cell subpopulations which differ in their morphogenetic properties
54. Cadherin expression in carcinomas: Role in formation of cell junctions and in the prevention ofinvasiveness
55. E-cadherin regulates cell growth by modulating proliferation-dependent {β}-catenin transcriptional activity
56. New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally
57. Raf induces TGFβ production while blocking its apoptotic but not invasive responses: A mechanism leading to increased malignancy in epithelial cells
58. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal
59. An analysis of Mek1 signaling in cell proliferation and transformation
60. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)
61. Epithelial cell plasticity in development and tumor progression
62. The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion
63. Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland
64. Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland
65. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis